MedPath

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma

Not Applicable
Completed
Conditions
Glaucoma Secondary to Eye Inflammation
Neovascular Glaucoma
Vascular Endothelial Growth Factor Overexpression
Intraocular Pressure
Registration Number
NCT04970251
Lead Sponsor
Siriraj Hospital
Brief Summary

Purpose: To investigate intravitreal aflibercept (IVA) injection as an adjunctive treatment to trabeculectomy with mitomycin C (TMC) and panretinal photocoagulation (PRP) for neovascular glaucoma (NVG).

Setting: Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Study design: Prospective interventional case series Methods: PRP and IVA (2 mg/0.05 ml) injection were given, and TMC was performed within 2 weeks after IVA. Additional PRP, laser suture lysis, subconjunctival 5-fluorouracil injection, and bleb needling were performed after TMC if indicated. Best-collected visual acuity (BCVA), intraocular pressure (IOP), surgical complications, and number of anti-glaucoma medications were collected.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Consecutive patients with neovascular glaucoma who presented at the Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand during November 2018 to October 2019.
  • Aged more than 18 year-old
Exclusion Criteria
  • Patients who received any anti-vascular endothelial growth factor treatment before participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Intraocular pressurePost-operative on month 36th

Intraocular pressure after trabeculectomy

Secondary Outcome Measures
NameTimeMethod
Visual acuityPost-operative on month 36th

Visual acuity of the studied eye

Numbers of medicationPost-operative on month 36th

Numbers of anti-glaucoma medications

Trial Locations

Locations (1)

Naris Kitnarong

🇹🇭

Bangkoknoi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath